Glyburide Oral Tablet 1.25Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Glyburide: Oral tablet (1.25mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_2558.JPG
Glyburide 1.25mg Tab
Teva Pharmaceuticals USA Inc
Pill Identification: N 342  |  1.25
Drug Image file DrugItem_2630.JPG
Glyburide 1.25mg Tab
Teva Pharmaceuticals USA Inc
Pill Identification: GLYBUR  |  477 477
Drug Image file DrugItem_2630.JPG
Glyburide 1.25mg Tab
Teva Pharmaceuticals USA Inc
Pill Identification: GLYBUR  |  477 477
Drug Image file DrugItem_13255.JPG
Glyburide 1.25mg Tab
CorePharma, LLC
Pill Identification: cor 123 

What is this Medicine?

GLYBURIDE (GLYE byoor ide) helps to treat type 2 diabetes. Treatment is combined with diet and exercise. The medicine helps your body to use insulin better.

CVS Pharmacy Patient Statistics for Glyburide: Oral tablet(1.25mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Glyburide 1.25mg Tablet

NDC: 000938342
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Type 2 Diabetes Mellitus

Sometimes used for but not FDA approved for the following conditions:
Gestational Diabetes

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Glyburide 1.25mg Tablet
Drug Image file DrugItem_2558.JPG
Teva Pharmaceuticals USA Inc
Pill Identification: N 342  |  1.25
Shape: round
Color: white

Reported Side Effects for Glyburide 1.25mg Tablet

Pancytopenia Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Liver Failure Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Hemolysis Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Flushing Incidence:
<0.1%*
Severity: MILD
Onset: RAPID
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Blood Vessels Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
No White Blood Cells Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Low Platelet Count Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
SIADH Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Aplastic Anemia Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Muscle Pain Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Low Blood Sodium Levels Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Hemolytic Anemia Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Rash With Pustules Incidence:
1.5%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
1.5%*
Severity: MODERATE
Onset: EARLY
Itching Incidence:
1.5%*
Severity: MILD
Onset: RAPID
Hives Incidence:
1.5%*
Severity: MILD
Onset: RAPID
Upset Stomach Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
1.8-39.0%*
Severity: MODERATE
Onset: EARLY
Heartburn Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Weight Gain Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Secondary Failure Incidence:
21.8-46.8%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Glyburide 1.25mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Glyburide 1.25mg Tablet(Glyburide)
Alcohol and Sulfonylureas(Glyburide)
Alcohol may interfere with the actions of Antidiabetic agents (Insulin or other drugs used to treat Diabetes). Alcoholic beverages can increase the risk of low blood sugar, or can cause increased blood sugar due to the calories in these beverages. Limit alcohol containing medicines and beverages if you are on Antidiabetic Agents. You should also learn how to recognize the signs of low blood sugar.
Minor Lifestyle Interaction
Tobacco and Glyburide 1.25mg Tablet(Glyburide)
Tobacco and Sulfonylureas(Glyburide)
If you use tobacco or are trying to quit tobacco use, you may need to monitor your blood sugar more frequently. Nicotine, a component of tobacco, can increase the blood sugar. Also, if you are trying to quit smoking, as your body adjusts to not smoking, your blood sugar levels may change; the actions of Antidiabetic Agents (medicines used to treat diabetes) may be increased and this could lead to low blood sugar. Know the symptoms of low or high blood sugar and report them if they occur. Monitor your blood sugar regularly.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Glyburide

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.